Pacira BioSciences, Inc. (PCRX)
|52 Week Range||28.54-58.09|
|1y Target Est||-|
|DCF Unlevered||PCRX DCF ->|
|DCF Levered||PCRX LDCF ->|
|Debt / Equity||76.82%||Buy|
Upgrades & Downgrades
Latest PCRX news
Pacira BioSciences Announces Fireside Chat at the H.C. Wainwright 25th Annual Global Investment Conf...
6 September 2023
TAMPA, Fla., Sept. 06, 2023 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (NASDAQ: PCRX) today announced its participation in an analyst-led fireside chat at the H.C. Wainwright 25th Annual Global Inve...
Pacira (PCRX) Q2 Earnings and Sales Miss, '23 View Updated
2 August 2023
Pacira (PCRX) announces weaker-than-expected second-quarter 2023 results. The company updates its 2023 financial guidance.
Pacira BioSciences, Inc. (PCRX) Q2 2023 Earnings Call Transcript
2 August 2023
Pacira BioSciences, Inc. (NASDAQ:PCRX ) Q2 2023 Earnings Conference Call August 2, 2023 8:30 AM ET Company Participants Susan Mesco - Head of IR David Stack - Chairman & CEO Charles Reinhart - CFO Con...
Why Is Pacira (PCRX) Down 11.8% Since Last Earnings Report?
2 June 2023
Pacira (PCRX) reported earnings 30 days ago. What's next for the stock?
Here's Why You Should Add Pacira (PCRX) Stock to Your Portfolio
15 May 2023
Pacira (PCRX) is witnessing strong growth on the back of its lead product, Exparel. Potential label expansion is set to boost sales in future quarters.
Pacira BioSciences to Participate in Fireside Chat at the 2023 RBC Capital Markets Global Healthcare...
9 May 2023
TAMPA, Fla., May 09, 2023 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (NASDAQ: PCRX) today announced that it will participate in an analyst-led fireside chat at the 2023 RBC Capital Markets Global He...
Pacira (PCRX) Q1 Earnings Miss Estimates, Revenues Beat
3 May 2023
Pacira (PCRX) misses on Q1 earnings but beats on revenues, even though volume growth of Exparel is offset by lower selling prices.
Biotech/Drug Stocks' Q1 Earnings Due May 3: UTHR, PCRX & More
2 May 2023
Let us take a look at what's in store for biotech/drug stocks UTHR, PCRX, CORT, AMRN and IONS, which are scheduled to report on May 3.
Pacira to Report First Quarter 2023 Financial Results on Wednesday May 3, 2023
26 April 2023
TAMPA, Fla., April 26, 2023 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (NASDAQ:PCRX) today announced that it will report its first quarter financial results before the open of the U.S. markets on We...